5-((4-aminonaphthalen-1-yl)diazenyl)-2-(4-((4-aminonaphthalen-1-yl)diazenyl)-2-sulfostyryl)benzenesulfonic acid

ID: ALA5278967

Chembl Id: CHEMBL5278967

Max Phase: Preclinical

Molecular Formula: C34H26N6O6S2

Molecular Weight: 678.75

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1ccc(/N=N/c2ccc(/C=C/c3ccc(/N=N/c4ccc(N)c5ccccc45)cc3S(=O)(=O)O)c(S(=O)(=O)O)c2)c2ccccc12

Standard InChI:  InChI=1S/C34H26N6O6S2/c35-29-15-17-31(27-7-3-1-5-25(27)29)39-37-23-13-11-21(33(19-23)47(41,42)43)9-10-22-12-14-24(20-34(22)48(44,45)46)38-40-32-18-16-30(36)26-6-2-4-8-28(26)32/h1-20H,35-36H2,(H,41,42,43)(H,44,45,46)/b10-9+,39-37+,40-38+

Standard InChI Key:  BEOHKTZPLVXCFG-NKPXSSHVSA-N

Alternative Forms

  1. Parent:

    ALA5278967

    ---

Associated Targets(Human)

SENP1 Tchem Sentrin-specific protease 1 (681 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SENP2 Tchem Sentrin-specific protease 2 (79 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SENP3 Tbio Sentrin-specific protease 3 (7 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 678.75Molecular Weight (Monoisotopic): 678.1355AlogP: 8.65#Rotatable Bonds: 8
Polar Surface Area: 210.22Molecular Species: ACIDHBA: 10HBD: 4
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 6#RO5 Violations (Lipinski): 4
CX Acidic pKa: -2.92CX Basic pKa: 2.92CX LogP: 7.29CX LogD: 3.06
Aromatic Rings: 6Heavy Atoms: 48QED Weighted: 0.05Np Likeness Score: -0.27

References

1. Wei J, Wang H, Zheng Q, Zhang J, Chen Z, Wang J, Ouyang L, Wang Y..  (2022)  Recent research and development of inhibitors targeting sentrin-specific protease 1 for the treatment of cancers.,  241  [PMID:35939992] [10.1016/j.ejmech.2022.114650]

Source